You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 59 No. 11, November 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Alzheimer Disease
 •Behavioral Neurology
 •Cognitive Disorders
 •Aging/ Geriatrics
 •Alert me on articles by topic

Time and Memory

Arch Neurol. 2002;59:1699-1700.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

AGING OF the nervous system is the theme for this issue of the ARCHIVES. Eight reviews are included which represent critical thinking of this complex and rapidly emerging scientific discipline. Evolutionary causes, molecular genetics and genomics, regeneration, and endocrinologic and neuropsychologic changes with normal and pathologic aging are included, written by major figures in the field.

Acquired mutations have accumulated for tens of thousands of years and have provided our species fitness to survive through natural selection. Fitness to reproduce and pass on one's genes to the next generation and for those progeny to survive has been the emphasis of evolution. After the reproductive years, evolution does not provide a great deal of support for enhanced survival. Aging is not a positive attribute to spend genetic energy to ameliorate its consequences. Evolution has not treated aging as an important biologic event beyond the reproductive and parenting years. The clinical consequences . . . [Full Text of this Article]


RELATED ARTICLE

Cerebrospinal Fluid Tau and {beta}-Amyloid 42 Proteins Identify Alzheimer Disease in Subjects With Mild Cognitive Impairment
M. Riemenschneider, N. Lautenschlager, S. Wagenpfeil, J. Diehl, A. Drzezga, and A. Kurz
Arch Neurol. 2002;59(11):1729-1734.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.